Tim FerrissHamilton Morris on Iboga, 5-MeO-DMT, the Power of Ritual, New Frontiers in Psychedelics, and More
At a glance
WHAT IT’S REALLY ABOUT
Hamilton Morris on rituals, risks, sustainability, and psychedelic research ethics
- Hamilton Morris highlights an upcoming publication of Alexander Shulgin’s newly found 1987 class recordings as a three-volume set titled “The Nature of Drugs.”
- The conversation critiques stigma and “closeting” around drug use, with Hamilton arguing openness is necessary for durable cultural change and that self-experimentation isn’t uniquely disqualifying in psychedelic science.
- Hamilton describes iboga/Bwiti practice as intensely ritualized and physically demanding, and says the ritual structure can magnify therapeutic impact beyond receptor-level explanations.
- The episode explores sustainability concerns around popular psychedelics, contrasting ecological harm from harvesting (e.g., iboga and toad venom) with scalable synthetic pathways (e.g., converting melatonin to 5-MeO-DMT).
- Hamilton recounts a xenon clinic visit that mixed striking subjective benefits with troubling safety practices, illustrating how malpractice and poor protocols can turn “novel therapies” dangerous.
IDEAS WORTH REMEMBERING
5 ideasA newly discovered Shulgin lecture series is being published as “The Nature of Drugs.”
Hamilton Morris says newly found recordings of Alexander “Sasha” Shulgin’s 1987 class are being published as a three-volume set titled "The Nature of Drugs," and he describes the material as “razor-sharp” and historically important in the context of worsening drug policy.
Hamilton challenges the idea that researcher drug experience automatically “biases” science.
Hamilton argues it’s inconsistent to treat personal experience with psychoactive drugs as uniquely disqualifying for researchers, noting that other fields don’t condemn expertise gained through direct exposure (e.g., ethnomusicology, sports commentary).
Ritual and context can dramatically amplify a drug’s effects, not just the chemistry.
Drawing on his participation in Bwiti iboga ceremonies, Hamilton says he came to see ritual as potentially as powerful as the substance, describing the ceremony as continuous dancing, drumming, fasting, and collective responsibility that magnified the experience.
Iboga’s modern addiction-treatment narrative is partly a U.S.-discovered application now feeding back into West Africa.
Hamilton describes how tramadol—cheap and widely available in parts of West Africa—has contributed to local dependence patterns, and he explains that the “anti-addictive” framing of ibogaine was discovered in the U.S. by Howard Lotsof and later validated in multiple lab replications.
Psychedelic demand can create real conservation pressure—synthetics can reduce it.
Hamilton warns that growing interest in psychoactive natural products can threaten plants and animals, including iboga (slow-growing and often harvested destructively) and the Sonoran Desert toad; he emphasizes synthetic alternatives can relieve ecological pressure.
WORDS WORTH SAVING
5 quotesThe short-term strategy is to be dishonest and to hide, and to lie about who you are and what you care about because if the dominant culture tells you that it is wrong, that it's immoral, that it's illegal, that's what you do.
— Hamilton Morris
But that only protects you. What if you have children who feel the same way? They're not protected. What about your grandchildren? If you wanna actually create a cultural change, you have to be open about who you are and what you care about.
— Hamilton Morris
I think a lot of it boils down to puritanical objections to euphoria and joy.
— Hamilton Morris
He says that every drug has no side effects for the first five years.
— Hamilton Morris
It's really like a near-death experience more than what people think of when they think of a psychedelic experience.
— Hamilton Morris
High quality AI-generated summary created from speaker-labeled transcript.
